| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.2B | $6.0B | $5.5B | $5.2B | $1.3B | $1.3B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.7B | $0.1B | $0.3B | $0.4B | $0.5B | $0.5B | $0.4B |
| Net Income | $0.7B | $0.4B | $0.0B | $0.1B | $0.4B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $18.50 | $11.85 | $0.99 | $3.26 | $11.67 | $4.49 | $2.80 | $2.92 |
| EPS (Diluted) | $18.16 | $11.70 | $0.98 | $3.21 | $11.49 | $4.43 | $2.76 | $2.88 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.9B | $15.3B | $14.6B | $14.0B | $14.3B | $13.4B | $12.5B | $12.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.1B | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.2B | $1.0B |
| Total Liabilities | $13.4B | $12.4B | $12.1B | $11.7B | $11.1B | $10.2B | $9.6B | $9.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.6B | $2.8B | $2.5B | $2.3B | $3.1B | $3.2B | $2.9B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.8B | $0.4B | $0.7B | $0.8B | $0.7B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.7B | $-0.5B | $-0.2B | $-0.5B | $-0.5B | $-0.6B | $-0.3B | $0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.3B | $-0.2B | $-1.1B | $-0.2B |